Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors

Clinical trial NCT07299747 · RECRUITING

Trial details

NCT number: NCT07299747
Sponsor: VelaVigo Bio Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Participants With Advanced Solid Tumor Malignancies

Start date: 2025-12-04
Primary completion: 2027-12-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.